General Information of the Compound
| Compound ID |
CP0778411
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(S)-2-[(2E,4E)-Hexadienoyl]-7-(5-methyl-2-{2-[(1E)-3-methylbuten-1-yl]oxazol-4-yl}ethoxy)-1,2,3,4-tetrahydroisoqunoline-3-carboxylic acid tert-butylamine salt
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C31H43N3O5
|
||||||||||||||||||
| Molecular Weight |
537.701
|
||||||||||||||||||
| Canonical SMILES |
C/C=C/C=C/C(=O)N1Cc2cc(OCCc3nc(/C=C/C(C)C)oc3C)ccc2C[C@H]1C(=O)O.CC(C)(C)N
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C27H32N2O5.C4H11N/c1-5-6-7-8-26(30)29-17-21-15-22(11-10-20(21)16-24(29)27(31)32)33-14-13-23-19(4)34-25(28-23)12-9-18(2)3;1-4(2,3)5/h5-12,15,18,24H,13-14,16-17H2,1-4H3,(H,31,32);5H2,1-3H3/b6-5+,8-7+,12-9+;/t24-;/m0./s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
AKXRQCXICDJIPB-ZOMMWANESA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00910, Peroxisome proliferator-activated receptor alpha
Protein ID: PT00915, Peroxisome proliferator-activated receptor gamma